Welcome to our dedicated page for Healthcare Svcs Group SEC filings (Ticker: HCSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Healthcare Services Group, Inc. (HCSG) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a NASDAQ-listed issuer incorporated in Pennsylvania, HCSG files annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K, along with associated exhibits and financial tables.
Through these documents, Healthcare Services Group reports detailed information on revenue from its environmental or housekeeping and laundry and dietary or dining and nutrition segments, cost of services, selling, general and administrative expenses, and segment margins. Filings also describe cash flow from operations, liquidity sources such as cash, marketable securities, and the revolving credit facility, as well as share repurchase activity and stockholders’ equity.
Current reports on Form 8-K capture material events and company announcements, including quarterly earnings releases and updates related to client restructurings or other significant developments. For example, HCSG has used Form 8-K to furnish press releases about results for periods ended September 30, 2025 and to provide information on a customer’s Chapter 11 filing and its estimated impact.
On Stock Titan, these filings are supplemented with AI-powered summaries that highlight key points from lengthy reports, helping readers understand how items such as bad debt expense, self-insurance actuarial adjustments, deferred compensation, and non-GAAP measures like EBITDA and Adjusted EBITDA affect reported results. Real-time updates from EDGAR, along with structured access to Forms 10-K, 10-Q, and 8-K, allow investors to review HCSG’s financial condition, risk disclosures, and capital structure without manually parsing every page of each filing.
Healthcare Services Group, Inc. (HCSG) President & CEO Theodore Wahl reported multiple equity transactions in common stock, restricted stock units (RSUs) and phantom stock. On December 31, 2025, he acquired 2,145 shares of common stock at $9.88 through the company’s Employee Stock Purchase Plan and 2,788 shares of phantom stock at $19.12 under a deferred compensation plan, with phantom stock payable in kind after his employment ends.
On January 3 and 4, 2026, several RSU awards were converted into common stock at a 1-for-1 rate, increasing his directly held common shares and reducing the related RSU balances, followed by a disposition of 35,450 common shares coded “F.” On January 5, 2026, he received a new grant of 93,693 RSUs at $0, which will vest 20% annually beginning on the first anniversary of the grant date. After these transactions, total direct and indirect beneficial ownership is reported as 604,211 shares.
Healthcare Services Group, Inc. EVP & Chief Operating Officer Andrew Kush reported multiple equity transactions in early
On
Separately, Kush received 1,628 shares of phantom stock on
Healthcare Services Group Inc. executive Vikas Singh, EVP & Chief Financial Officer, reported several equity transactions in company stock. On January 3, 2026, 3,980 Restricted Stock Units converted into 3,980 shares of common stock at an exercise price of $0, leaving him with 3,980 common shares held directly. On January 5, 2026, 1,900 common shares were disposed of at $0, with 2,080 common shares remaining directly owned after this transaction.
In the derivative holdings, after the January 3, 2026 conversion, Singh held 15,918 Restricted Stock Units. On January 5, 2026, he was awarded an additional 17,813 Restricted Stock Units at a price of $0, resulting in 17,813 Restricted Stock Units beneficially owned following that grant. Footnotes state that these Restricted Stock Units vest at a rate of 20% annually, beginning on the first anniversary of the respective grant dates of January 3, 2025 and January 5, 2026.
Healthcare Services Group (HCSG) reported an insider transaction on a Form 4. On 10/27/2025, the company’s EVP/General Counsel/Corporate Secretary sold 20,996 shares of common stock at a $19.04 weighted average price across multiple trades. Following the sale, the reporting person directly owns 20,509 shares.
The filing notes the transaction was executed in multiple trades, and detailed trade data will be provided upon request.
Healthcare Services Group (HCSG) executive EVP & Chief Operating Officer filed a Form 4 reporting an open-market sale of 28,612 shares of common stock on 10/28/2025 at a weighted average price of $19.13.
Following the transaction, the reporting person beneficially owns 18,859 shares, held directly. The filing notes the sale was executed in multiple trades and that detailed trade breakdowns are available upon request.
Healthcare Services Group (HCSG) reported stronger Q3 2025 results. Revenue rose to $464,338 thousand and net income increased to $42,953 thousand, translating to diluted EPS of $0.59. Operating performance reflected lower interest expense and higher investment income.
Results were shaped by special items. The company received Employee Retention Credit refunds of $31.8 million in the quarter ($51.8 million year‑to‑date), recognized $34.2 million as a reduction to costs of services and $5.3 million of related interest income, and recorded a $12.3 million deferred ERC liability tied to a 2021 period. Credit risk remained elevated: following Genesis Healthcare’s Chapter 11 filing, HCSG applied a 100% allowance to Genesis receivables and recorded bad debt expense of $2.7 million in Q3 and $63.9 million year‑to‑date. Cash, cash equivalents and restricted cash equivalents ended at $124,420 thousand, supported by net cash provided by operating activities of $127,581 thousand for the nine months. The company also repurchased $27,271 thousand of treasury stock in Q3.
Healthcare Services Group, Inc. (HCSG) furnished a press release announcing its earnings for the three months ended September 30, 2025. The press release is provided as Exhibit 99.1 and incorporated by reference.
The company states that the information, including Exhibit 99.1, is being furnished and is not deemed filed for purposes of Section 18 of the Exchange Act. An Inline XBRL cover page (Exhibit 104) is included.
Kurt Simmons Jr., a director of Healthcare Services Group, Inc. (HCSG), reported acquiring 892 shares of common stock on 09/30/2025 at an effective price of $16.83 per share by electing to receive shares in lieu of cash board fees under the company's 2020 Omnibus Incentive Plan. The election was made in November 2024 and applies to fees earned in 2025 in compliance with the issuer's blackout guidelines. Following the reported transaction, Simmons beneficially owns 26,596 shares in total, consisting of 23,790 vested DSUs and 2,806 unvested DSUs. The DSUs are fully vested and will be settled in shares 90 days following separation from the board, with an option for further deferral under Code Section 409A. The Form 4 was signed by power of attorney on 10/02/2025.
Thomas Gerard Whalen, a director of Healthcare Services Group, Inc. (HCSG), reported an acquisition on 09/30/2025 of 149 shares of common stock at an effective price of $16.83 per share. The shares reflect the election to receive fully vested Deferred Stock Units (DSUs) instead of cash director fees for 2025; the filing states the election was made in May 2025. The report breaks the total into 2,806 unvested DSUs and 214 vested DSUs, and notes DSUs will be settled in shares 90 days after separation from board service, with an option for further deferral under Code Section 409A.
Mackenzie Financial Corporation reports beneficial ownership of 4,128,499 common shares of Healthcare Services Group Inc., representing 5.66% of the class. The filing states Mackenzie holds sole voting and dispositive power over these shares and that the holdings were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer. The statement is filed under Schedule 13G reporting rules and identifies Mackenzie as an investment adviser organized in Ontario, Canada, with the shares listed under CUSIP 421906108. The filing includes a certification of accuracy signed by Mackenzie’s Vice‑President & Chief Compliance Officer.
FAQ
What is the current stock price of Healthcare Svcs Group (HCSG)?
What is the market cap of Healthcare Svcs Group (HCSG)?
